Should I buy Life360 (LIF) stock or is it too late?
No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.
Firm-by-firm track record on Life360
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Stifel | 67 % | +46.9 % | 6 | $76 +79% |
| Canaccord Genuity | 33 % | +4.9 % | 6 | $94 +121% |
| UBS | 20 % | -26.9 % | 5 | $60 +41% |
✅ Reasons to believe
- 80% of analysts rate it a buy (Buy consensus, 5 ratings) — a sign of market conviction.
- Median price target $60, i.e. +41% from the current price ($43).
- The most reliable firm on LIF, Stifel (67% hit rate, 6 scored calls), targets $76 (call made on January 27, 2026, maturing on January 27, 2027) (+79%) in its most recent call, and $92 (call made on October 24, 2025, maturing on October 24, 2026) (+116%) in the one coming due soonest.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 5 ratings, 1 is neutral.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- Volatile stock: sharp swings — including steep drops — are part of its profile.
- No dividend: your return depends only on price appreciation.
The analyst consensus on LIF
Median target $60 (+41%) · 5 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Life360 now?
We won't decide for you. The facts: 80% of analysts rate it a buy, median target $60 (+41%), and Stifel (most reliable on LIF, 67%) targets $76. Weigh that against valuation and volatility. This is not personalized advice.
Is it too late to invest in Life360?
Not according to analysts: the median target ($60) is still +41% above the current price ($43) (most reliable on LIF: Stifel, 67%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Life360 still worth investing in?
It depends on the gap between the price ($43) and its estimated value: analysts target $60 on median (+41%), with 80% buys (most reliable on LIF: Stifel, 67%). Cross-check with their real reliability on LIF and the cautions above. Information, not advice.
What's the main risk in buying LIF?
The consensus is not unanimous: of 5 ratings, 1 is neutral.
→ Go deeper: the full Life360 profile (consensus, analyst reliability, price target, performance).